The investment over the next eight years could be the largest ever industry-academic agreement of its kind in the U.S., the ...

Metsera is a new GLP-1 player with a Phase 2b injectable and promising oral and amylin drugs in development. Learn why MTSR ...

Eli Lilly has expanded its partnership with Purdue University, committing up to $250 million to fuel pharmaceutical ...